The Maine Prescription Drug Affordability Board (MPDAB) was established in 2019 pursuant to MRS Title 5 Chapter 167-1. The Maine Office of Affordable Health Care provides staffing support to the Board.
MPDAB Mission: To determine annual spending targets for prescription drugs purchased by Maine public payers and make recommendations to achieve the targets.
MPDAB Vision: Board recommendations will target strategies to achieve prescription drug affordability while maintaining safety and ensuring clinically appropriate use. The spending targets will be based upon a 10- year rolling average of the medical care services component plus a reasonable percentage for inflation and minus a spending target determined by the board for pharmacy savings. In addition, spending targets will be determined on specific prescription drugs that may cause affordability challenges to enrollees.
Board Members:
- Chair: Kelsie Snow, PharmD
- Peter Hayes
- Sharon Treat
- Susan Wehry, MD
- Julia Redding, DO
- Noah Nesin, MD (alternate)
- Jennifer Reck (alternate)
- Rhonda Selvin, FNP (alternate)
Upcoming Meetings
View upcoming meetings
Meeting Records
View meeting records